Results 311 to 320 of about 181,705 (382)
Renal Leukocyte Chemotactic Factor 2 (ALECT2) Amyloidosis With Concurrent IgA Nephropathy: A Case Report and Literature Review. [PDF]
Gong Q, Gao L, Li H, Zhong R, Huo Y.
europepmc +1 more source
Cystatin C as Biomarker for the Evaluation of Renal Outcome in AL Amyloidosis
ABSTRACT Cystatin C (CysC) has emerged as a novel and potentially more reliable biomarker for the estimation of glomerular filtration in the general population in patients with various conditions. In AL amyloidosis, the current renal staging system and renal response criteria are based on proteinuria and creatinine‐based eGFR.
Foteini Theodorakakou+18 more
wiley +1 more source
Inherited transthyretin cardiac amyloidosis presenting with diastolic heart failure and gastrointestinal symptoms: a case report and literature review. [PDF]
Wang J, Zhang R, Li Z, Zhang W.
europepmc +1 more source
Main Points In a pre‐symptomatic mouse model of Alzheimer disease, despite higher amyloid‐β load females display less plaques than males. More efficient synaptic transmission as well as less microgliosis point to better early coping with pathogenesis in females.
Thomas Chaigneau+7 more
wiley +1 more source
Vascular-variant cardiac amyloid: Cardiac MRI and histopathological appearances. [PDF]
Flynn S, Fadalla K, Fabre A, Dodd JD.
europepmc +1 more source
Prevalence of cardiac fibrosis and sarcoidosis in patients with advanced conduction system disease. Abstract Background Conduction system disease may represent an early manifestation of underlying structural heart disease, including infiltrative disorders.
Jeremy William+12 more
wiley +1 more source
Case Series: Genetic mimics of hypertrophic cardiomyopathy in elderly. [PDF]
Chumakova OS+5 more
europepmc +1 more source
Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
ABSTRACT Microglia, the resident immune‐competent cells of the brain, become dysfunctional in Alzheimer's disease (AD), and their aberrant immune responses contribute to the accumulation of pathological proteins and neuronal injury. Genetic studies implicate microglia in the development of AD, prompting interest in developing immunomodulatory therapies
Madison K. Kuhn, Elizabeth A. Proctor
wiley +1 more source